Advances and Challenges of Epidemic Outbreaks in the Post-COVID-19 Era in China
Open Access
- 16 March 2023
- journal article
- editorial
- Published by Wolters Kluwer Health in Infectious Diseases & Immunity
- Vol. 3 (2) , 49-51
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- VV116 versus Nirmatrelvir–Ritonavir for Oral Treatment of Covid-19New England Journal of Medicine, 2023
- Diagnosis and Treatment Protocol for COVID-19 Patients (Tentative 9th Version)Infectious Diseases & Immunity, 2022
- Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21The Lancet, 2022
- Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trialSignal Transduction and Targeted Therapy, 2021
- The COVID-19 Vaccine in Clinical Trials: Where Are We Now?Infectious Diseases & Immunity, 2021
- What to do next to control the 2019-nCoV epidemic?The Lancet, 2020